MODERN CONCEPTS OF POTENTIALS FOR THE PREVENTION OF ATOPIC DERMATITIS IN CHILDREN USING PROBIOTICS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article summarizes the modern concepts of potentials for the prevention of atopic dermatitis in children using probiotics. A review of studies aimed at attempts to prevent the atopic dermatitis in the prenatal and postnatal periods is presented. Evidence of efficacy of use of the isolated strain of Lactobacillus ramnosus GG during the last 4 weeks of pregnancy and then long-term use during lactation are discussed. Moreover, the preventive effect of Lactobacillus is amplified in cases where newborn receives this medication for a long time in parallel with lactating women.

Full Text

Restricted Access

About the authors

K. N Monakhov

St. Petersburg Medical University n.a. Acad. I.P. Pavlov

Email: knmonakhov@mail.ru
Prof. at the Department of Dermatology St. Petersburg

D. K Dombrovskaya

St. Petersburg Medical University n.a. Acad. I.P. Pavlov

St. Petersburg

References

  1. Asher M.I., Montefort S., Björkstän B., Lai C.K., Strachan D.P., Weiland S.K., Williams H.; ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases one and three repeat multicountry cross-sectional surveys. Lancet. 2006; 368(9537): 733-43.
  2. Sansonetti P.J., Medzhitov R. Learning tolerance while fighting ignorance. Cell. 2009; 138(3): 41620.
  3. Prescott S.L., Macaubas C., Holt B.J. Smallacombe T.B., Loh R., Sly P.D., Holt P.G. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J. Immunol. 1998; 160: 47307.
  4. Cabana M.D., McKean M., Wong A.R., Chao C., Caughey A.B. Examining the hygiene hypothesis: the Trial of infant probiotic supplementation. Paediatr. Perinat. Epidemiol. 2007; 21(Suppl 3): 238.
  5. Renz-Polster H, David M.R., Buist A.S., Vollmer W.M., O'Connor E.A., Frazier E.A., Wall M.A. Caesarean section delivery and the risk of allergic disorders in childhood. Clin. Exp. Allergy. 2005; 35: 146672.
  6. Sanders M.E., Guarner F., Guerrant R., Holt P.R., Quigley E.M., Sartor R.B., Sherman P.M., Mayer E.A. An update on the use and investigation of probiotics in health and disease. Gut. 2013; 62(5): 78796.
  7. Kuitunen M. Probiotics and prebiotics in preventing food allergy and eczema. Curr. Opin. Allergy Clin. Immunol. 2013; 13(3): 2806.
  8. Conway P.L., Gorbach S.L., Goldin B.R. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J. Dairy Sci. 1987; 70(1): 112.
  9. Суржик А.В. Влияние пробиотической культуры Lactobacillus rhamnosus GG на иммунный ответ организма. Вопросы современной педиатрии. 2009; 8(2): 548.
  10. Goldin B.R., Gorbach S.L., Saxelin M., Barakat S., Gualtieri L., Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 1992; 37(1): 121-28.
  11. Андреева И.В. Современные доказательные данные эффективности применения Lactobacillus rhamnosus GG и Bifidobacterium lactis Вb-12 в педиатрической практике. Вопросы современной педиатрии. 2011; 10(1): 507.
  12. Lim K. Antimicrobial susceptibility of Bifidobacteria. J. Dairy Sci. 1993; 76: 2168-74.
  13. Saxelin M. Safety of commercial products with viable Lactobacillus. Strains. Infec. Dis. Clin. Pract. 1996; 5: 331-35.
  14. Laitinen K., Kalliomaki M., Poussa T., Lagström H., Isolauri E. Evaluation of diet and growth in children with and without atopic eczema: followup study from birth to 4 years. Br. J. Nutr. 2005; 94(4): 565-74.
  15. Tanaka A., Jung K., Benyacoub J., Prioult G., Okamoto N., Ohmori K., Blum S., Mercenier A., Matsuda H. Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-y. Exp. Dermatol. 2009; 18(12): 1022-27.
  16. Dotterud C.K., Storro O., Johnsen R., Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br. J. Dermatol. 2010; 163(3): 616-23.
  17. Abrahamsson T.R., Jakobsson T., Böttcher M.F., Fredrikson M., Jenmalm M.C., Björkstän B., Oldaeus G. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2007; 119(5): 1174-80.
  18. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet. 2001; 357: 1076-79.
  19. Doege K., Grajecki D., Zyriax B.C., Detinkina E., Zu Eulenburg C., Buhling K.J. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood - a meta-analysis. Br. J. Nutr. 2011; 26: 1-6.
  20. Kopp M.V., Hennemuth I., Heinzmann A., Urbanek R. Randomized, Double-Blind, Placebo-Controlled Trial of Probiotics for Primary Prevention: No Clinical Effects of Lactobacillus GG Supplementation. Pediatrics. 2008; 121(4): 850-56.
  21. Wickens K., Black P., Stanley T.V., Mitchell E., Barthow C., Fitzharris P., Purdie G., Crane J. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin. Exp. Allergy. 2012; 42: 1071-79.
  22. Kalliomаki M., Salminen S., Poussa T., Arvilommi H., Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003; 31(9372): 1869-71.
  23. Kalliomаki M., Salminen S., Poussa T., Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2007; 119: 1019-21.
  24. Taylor A.L., Dunstan J.A., Prescott S.L. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J. Allergy Clin. Immunol. 2007; 119: 184-91.
  25. Prescott S.L., Wiltschut J., Taylor A., Westcott L., Jung W., Currie H., Dunstan J.A. Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Allergy. 2008; 63: 1481-90.
  26. Jensen M.P, Meldrum S., Taylor A.L., Dunstan J.A., Prescott S.L. Early probiotic supplementation for allergy prevention: long-term outcomes. J. Allergy Clin. Immunol. 2012; 130: 1209-11.
  27. LahtinenS.J.,BoyleR.J.,KivivuoriS.,OppedisanoF, Smith K.R., Robins-Browne R., Salminen S.J., Tang M.L. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J. Allergy Clin. Immunol. 2009; 123: 499-501.
  28. Rautava S., Kalliomаki M., Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J. Allergy Clin. Immunol. 2002; 109: 119-21.
  29. Boyle R.J., Ismail I.H., Kivivuori S., Licciardi P.V., Robins-Browne R.M., Mah L.J., Axelrad C., Moore S., Donath S., Carlin J.B., Lahtinen S.J., Tang M.L. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy. 2011; 66: 509-16.
  30. Bottcher M.F, Abrahamsson T.R., Fredriksson M., Jakobsson T., Björkstén B. Low breast milk TGF-beta2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy. Pediatr. Allergy Immunol. 2008; 19: 497-504.
  31. Prescott S.L., Wickens K., Westcott L., Jung W., Currie H., Black P.N., Stanley T.V., Mitchell E.A., Fitzharris P, Siebers R., Wu L., Crane J; Probiotic Study Group. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferongamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin. Exp. Allergy. 2008; 38: 1606-14.
  32. Kuitunen M., Kukkonen A.K., Savilahti E. Impact of maternal allergy and use of probiotics during pregnancy on breast milk cytokines and food antibodies and development of allergy in children until 5 years. Int. Arch. Allergy Immunol. 2012; 159: 162-70.
  33. Wickens K., Black P.N., Stanley T.V., Mitchell E., Fitzharris P., Tannock G.W., Purdie G., Crane J.; Probiotic Study Group. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebocontrolled trial. J. Allergy Clin. Immunol. 2008; 122: 788-94.
  34. Majamaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy. Clin. Immunol. 1997; 99(2): 179-85.
  35. Isolauri E., Arvola T., Sutas Y., Moilanen E., Salminen S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy. 2000; 30(11): 1604-10.
  36. Viljanen M., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005; 60(4): 494-500.
  37. Kuitunen M. Probiotics and Prebiotics in Preventing Food Allergy and Eczema. Curr. Opin. Allergy Clin. Immunol. 2013; 13(3): 280-86.
  38. Thomas D.W., Greer F.R.; American Academy of Pediatrics Committee on Nutrition. American Academy of Pediatrics section on gastroenterology, hepatology, and nutrition. Probiotics and prebiotics in pediatrics. Pediatrics. 2010; 126: 1217-31.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies